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ne of the many tangential benefits of the computer revolution
has been the development of chemometrics, which has been
adopted for many applications in analytical chemistry. Chemo-
metrics uses statistical and mathematical methods to unravel
chemical problems. As described in various textbooks, chemo-
metrics plays a decisive role in process analytical chemistry, both
in monitoring and control applications, and is increasingly used in areas
such as analyzing images and optimizing molecular structures on the
basis of their properties and activities (1–4).
Nuclear magnetic resonance (NMR) of molecules in living tissue is a new
challenge for chemometrics. NMR can be performed as either spectroscopy
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(MRS) or imaging (MRI). (The term “nuclear” is omitted in a
clinical environment because it is often incorrectly associated
with nuclear radiation.) MRI is an established medical tech-
nique for examining different internal organs like the brain,
prostate, and heart and is an accepted clinical tool for imaging
blood vessels and musculoskeletal tissue.
In particular, MRI is the most useful imaging modality for
examining brain tumors. Acquiring MR images of representa-
tive cross-sectional slices of the head to detect and local-
ize a brain tumor is a daily occurrence. One or more
small tissue samples called biopsies are then removed
from the localized tumor to determine identity and
grade. Depending on the diagnosis, a patient next re-
ceives chemotherapy, radiation treatment, or undergoes
surgery. However, a biopsy is far from optimal for the di-
agnosis of brain tumors because it is invasive, subject to
sampling errors, and provides no information about the
tissue heterogeneity of the tumor. Therefore, MRI,
MRS, and a combination of these techniques called mag-
netic resonance spectroscopic imaging (MRSI) are being
explored in clinical trials in the hope of providing nonin-
vasive brain tumor diagnoses.
Here lies the major challenge for chemometrics: No
breakthroughs are expected in clinical MR examinations
of brain tumor patients because analysis and interpreta-
tion of the acquired MR data are still the major bottle-
neck. But the combination of MRI, MRSI, and chemo-
metrics may advance the fast, noninvasive diagnosis of
brain tumors.
In this feature, we will explain some basic elements of
MRI and MRSI in human brain studies and focus on the
possibilities and added value that chemometrics can offer
the techniques.
MRI basics 
Figure 1a is an MR image that shows the spatial distribu-
tion of the proton NMR signal of water in a cross-sec-
tional tissue slice of a human brain tumor. The voxel
(volume element) of each pixel in an image is ~0.01 cm3. 
Manipulating the MR image contrast by varying ac-
quisition parameters has proven to be MRI’s greatest
strength. The spin-echo imaging technique is used rou-
tinely in the clinical environment to collect data. Just like
any other MR sequence, spin-echo imaging uses radio
frequency (rf) pulses and magnetic field gradients, which
are applied to a subject placed inside a homogeneous
static magnetic field. The pulse sequence generates the
proton NMR signal, while the gradient sequence spatial-
ly encodes the proton NMR signal. 
The proton density () and the spin–lattice (T1) and
spin–spin (T2) relaxation times are parameters that deter-
mine the NMR intensities of the different tissue types.
The echo time (TE) and the repetition time (TR) are ac-
quisition parameters that determine the -, T1-, and T2-
sensitivity of the acquired spin-echo images. According
to Equation 1, the signal intensity (S) in each voxel can
be described to a first-order approximation (assuming that TR
>> TE) as
S =  . [1 – exp(–TR/T1)] . exp(–TE/T2) (1)
S is heavily -weighted if TR is long with respect to T1 and TE
is short with respect to T2, T2-weighted if TR is long and TE is
long, and T1-weighted if TR is short and TE is long. Thus, on
(a)
(b)
FIGURE 1. MR data acquired from a cross-sectional image slice
through the brain tumor.
(a) The MR image shows the proton NMR signal of water on a high spatial reso-
lution. The grid indicates the lower spatial resolution of the spectroscopic image.
(b) Part of the spectroscopic image showing the MR spectra from adjacent
spectroscopic voxels in the tumor region. Each spectrum shows the proton
NMR signal of various metabolites like NAA, Cho, and Cr. The differences be-
tween the spectra of adjacent spectroscopic voxels in the MR spectra indicate
the large tissue heterogeneity of the brain tumor.
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the basis of a tissue’s , T1, or T2 values, different intensities are
recorded in the -, T1-, or T2-weighted images. 
In the hospital, the -, T1-, and T2-weighted images are com-
monly acquired with the spin-echo technique for different com-
binations of TE and TR. These images are usually combined for
normal brain tissue segmentation, which is the discrimination
between white matter, gray matter, and cerebrospinal fluid.
However, additional feature images are required for the seg-
mentation of the different tissue types in the image within a
tumor bed. A contrast agent is usually introduced to the patient
before collecting a T1-weighted spin-echo image. The contrast
agent shortens the T1 of brain tissue, which has a disrupted vas-
cular structure as a result of tumor proliferation.
Understanding MRSI of brain tumors 
Figure 1b is an MR spectroscopic image that shows the spatial
distribution of the proton NMR signal of various metabolites in
a cross-sectional tissue slice of a human tumor. The voxel size in
an MR spectroscopic image has to be ~1 cm3 to acquire proton
NMR signals of metabolites with an adequate S/N. In addition,
only metabolites with concentrations >0.1 mM are visible in the
MR spectrum. A spin-echo-based pulse sequence in combina-
tion with additional pulses is often used
in MRSI to suppress the large proton
signals of water and possible fat that
would spoil the spectrum (5).
Proton signals for metabolite mark-
ers N-acetyl-aspartate (NAA), phos-
phocreatine and creatine combined
(Cr), choline-containing compounds
(Cho), and lactate (Lac) can be ob-
served in spatially resolved MR spec-
tra. The metabolite levels in tumor and
normal brain tissue are quite different.
For example, the concentration of
NAA, a neuronal marker, is low in
tumor tissue because tumors charac-
teristically lose neuronal cells. Cho is
elevated in tumor tissue because mem-
brane synthesis and degradation in-
creases. The Cr signal is reduced or
even absent in tumor spectra because
of the reduced energy metabolism in tumor tissue. Lac is usu-
ally observed in tumor spectra because it indirectly marks ab-
normal glycolysis. Thus, these metabolite levels, as reflected by
the MR signal intensities, provide potential markers for tumor
identity and grade. 
However, the observed signal intensities in the MR spectra
may not directly reflect the relative concentrations of the
metabolites present in the spectroscopic voxels. Different com-
binations of TE and TR yield different spectral profiles in the
voxels because the various metabolites have different T1 and T2
values. Only MR spectra of voxels acquired at identical combi-
nations of TE and TR can be compared for characterization.
Usually, short echo- or long echo-time spectra are acquired. 
The acquisition of short echo-time spectra reduces the sig-
nal loss due to T2. This means that spectra with higher S/N are
obtained, and additional resonance peaks of metabolites with
short T2 values such as myo-inositol, glutamate, and glutamine
are detected, which may be disease markers. On the other
hand, a broad background signal appears in the spectra from
macromolecules with short T2 values. Although short echo-
time spectra provide more biochemical information, they are
more difficult to analyze and interpret because of the broad
peaks from short T2 macromolecules.
Diagnosing brain tumors
MRI and MRSI will irrevocably improve patient diagnosis and
treatment if viable tumor tissue can be distinguished from ab-
normal, nonmalignant tissue types, such as necrosis, edema, and
possibly radiation necrosis and scar tissue, within the tumor bed.
Moreover, the delineation of a viable tumor will facilitate non-
invasive diagnosis or at least guide the collection of biopsies, aid
the study of the effects of chemotherapy or radiation treatment
over time, and help monitor patients after surgery.
The standard -, T1-, and T2-weighted MR images hardly
allow proper tissue discrimination within the tumor region.
Contrast agents enhance lesion-imaging in areas where the
blood–brain barrier is damaged. This
barrier may be affected to various de-
grees, and the extent of the tumor tis-
sue may be under- or overestimated.
If there is a significant leak in the
blood–brain barrier, then blood will
flow through the surrounding healthy
tissue and lead to an overestimation of
tumor area. Tumors are underestimat-
ed if the barrier is damaged only slight-
ly. The blood will stay in the vessels,
and the tumor can hardly be seen in
the image.
Combined MRI/MRSI studies have
revealed that images of a contrast-en-
hanced lesion are much smaller than
the region of actual abnormal metab-
olism (6). MRSI studies found that
metabolite levels vary widely for indi-
vidual tumors. Large standard devia-
tions in metabolite levels of one tumor type and substantial over-
lap of metabolite levels between different tumor grades have
been measured (6). Other studies showed clear differences be-
tween necrosis and other abnormal tissue, although these stud-
ies are limited by low spatial resolution (6). Because MRSI and
MRI are complementary techniques, chemometrics should fa-
cilitate the fusion of morphologic (MRI) and metabolic
(MRSI) data to improve the delineation of brain tumors.
The data analysis methodology must quickly process the
large stream of MRI and MRSI data and deal with difficulties.
Due to time constraints, spectroscopic images with low S/N
are typically acquired. Moreover, a patient can move during MR
acquisition, and the resulting artifacts may complicate the data
analysis. In vivo examinations also hamper any form of “sample
preparation” that would facilitate data analysis. Therefore, MR
examinations of brain tumor patients are, to a large extent, de-
pendent on proper data processing.
A chemometric methodology will only be accepted in the
clinical environment if it produces reliable results with minimal
subjective user interaction. Laboratory assistants are usually un-
familiar with sophisticated data analysis techniques. The sim-
plicity and transparency of the data analysis methodology is
crucial for its implementation in a hospital. 
Processing MR images
Image registration. Image registration, also called image
matching, compensates for patient movement during the MR
examination or combines images from serial MR examinations
of a single patient. Serial MR examinations are performed to
study tumor growth or shrinkage after radiation treatment. A
suitable registration algorithm should be able to quickly detect
the same tissue slice as the one previously measured.
Precautions are taken to restrict the movement of the head
during an MR examination of a brain tumor patient. Therefore,
patient movement results in only small shifts, which can be cor-
rected with a simple cross-correlation method between different
images (7). However, a disadvantage of cross-correlation meth-
ods is their sensitivity to intensity differences in different con-
trast images. Feature-based registration methods can help the
radiologist find the target position of the tissue slice in serial
brain tumor MR examinations. These methods align images by
translational, rotational, and uniform scaling transformations. 
Previous registration points that are insensitive to changes in
tissue and acquisition conditions, for example, edges and cor-
ners in normal brain tissue regions, are sought for matching.
Then a suitable algorithm like the Procrustes algorithm can be
used to find the least-squares solution by minimizing the dis-
tance among all paired points in the two images (8). The exe-
cution time of the algorithm linearly decreases with the num-
ber of registration points used. Multiscale approaches using
wavelets have been proposed to increase the computation
speed of registration algorithms. With wavelet analysis, image
representations on different spatial resolutions allow the sam-
pling of fewer registration points sufficient for adequate regis-
tration (9). 
Removal of nonbrain tissue. Image segmentation of brain
tissue is simplified if nonbrain material such as bone, skull, face
muscles, and air is removed from the images. The removal of
these materials can simply be achieved by drawing a region of
interest in the image containing only brain tissue. A simple al-
gorithm for the automatic removal of skull tissue and air is pre-
sented in Ref. 10. The method is based on the construction of
a radius image with the -weighted image, because -weight-
ing clearly defines the transition between brain tissue and
skull. The -weighted image can subsequently be used as a
mask image to remove skull tissue and air outside the brain
from other registered contrast images. Another accepted
method that requires minimal user intervention to remove
the skull from the image is based on a multiresolution algo-
rithm (11, 12).
Image filtering. Image filtering is applied in brain MR
imaging of tissue slices thinner than 1 cm to ensure low S/N
ratios. A popular MR image filter is the nonlinear anisotrop-
ic diffusion filter, which improves the S/N without blurring
the fine structural details in the image (13, 14). 
Field inhomogeneity correction. Magnetic field inhomo-
geneities decrease the digitized signal amplitude (pixel inten-
sity) of a voxel. For example, in a typical MR scan, the inho-
mogeneous static magnetic field (B0) of the scanner broadens
the water resonance peak because the resonance frequency is
proportional to the strength of the applied magnetic field,
resulting in a decrease in pixel intensity. Usually, the spatial
inhomogeneity of this field is negligible. 
However, the spatial inhomogeneity of the rf magnetic
field (B1) produced by the coil surrounding the head may be
significant. The coil excites proton spins and receives the
proton signal of a selected tissue slice. Regional field strength
differences inside the coil are caused by inhomogeneities in
rf coil sensitivity and rf transmission. The nonuniform exci-
tation and reception profiles of the coil yield nonuniform in-
tensity variations across the image, which depend on the coil
design, slice orientation, pulse sequence, and even the pa-
tient. The nonuniformity appears as a low spatial frequency
component in the image and is commonly removed by two-
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FIGURE 2. LDA applied to the segmentation of a multivariate image.
(a) Discriminant scores of the training pixels for white matter, gray matter,
cerebrospinal fluid, and tumor in the ld1–ld2 score plot. (b) Discriminant
scores of all pixels in the same ld1–ld2 score plot. (c) Classification of all pix-
els based on the Euclidean distance: The shortest distance to a class center
determines the class membership of the pixel. (d) Classification of all pixels
shown in the corresponding image domain. The tissue classes are color-
coded: White is tumor, light gray is cerebrospinal fluid, gray is gray matter,
and dark gray is white matter. 
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dimensional (2-D) low-pass filtering, which is distinct from
S/N ratio improvement. 
An experimental method to correct for image nonuniformi-
ty is to image a test sample with a uniform NMR intensity
across the field of view with the coil surrounding the patient’s
head. A phantom filled with water is usually imaged for this
purpose (15). The correction coefficients for producing uni-
form intensity images of the sample are stored in the comput-
er and subsequently applied to patient brain MR images. An
important disadvantage of this method is that the rf penetra-
tion through the sample is not the same as of the patient.
Multivariate image segmentation. A multivariate image
consists of a series of MR images of the
same tissue slice such as -, T1-, and T2-
weighted MR images. In this case, seg-
mentation means dividing a multivari-
ate image into regions of different tis sue
types. Multivariate image segmentation
starts after removal of nonbrain tissue
and, if necessary, after image registra-
tion, field inhomogeneity correction,
and image noise removal. 
The simplest use of multivariate
image segmentation is to combine two
registered MR images. For each pixel,
the intensity in one image is plotted
against the intensity in the other
image to define a 2-D variable, or fea-
ture space. Image segmentation is
achieved by defining regions in the 2-
D feature space corresponding to the
different tissue types. In case of three
registered images, a 3-D feature space can be defined in which
the different tissue types are located at different positions.
However, this approach becomes more difficult if more than
three registered images need to be combined. The lack of visu-
al inspection complicates the isolation of different clusters cor-
responding to different tissue types in the multidimensional fea-
ture space. Pattern recognition techniques, an important area of
chemometrics, have been used to deal with this problem. 
Principal component analysis (PCA) is the most popular
technique in the field of chemometrics and has been used in the
visualization of multivariate image data (16). PCA transforms a
set of registered MR images into a new set of abstract images,
called the PCA score images, in such a way that the image con-
trast information is condensed into the first few PCA score im-
ages (17). By defining a 2-D feature space with the first two PCA
score images, an expert can delineate the different tissue regions
in this 2-D plot based on 80–90% of the image contrast vari-
ance present in the set of MR images. 
However, due to possible field inho-
mogeneities and the partial volume ef-
fect, also referred to as the mixing ef-
fect of multiple tissue types within one
voxel, no distinct groups of pixels ap-
pear in the 2-D PCA score plot. In fact,
no dedicated technique to date is able
to reduce the dimension of multivari-
ate MR images in such a way that dis-
tinct tissue clusters can be visualized.
User interaction is required to improve
the segmentation of multivariate brain
MR images. Supervised pattern recog-
nition methods such as discriminant
analysis, neural networks, and fuzzy
clustering methods have been applied
to the segmentation of multivariate MR
images. However, these methods may
also produce misleading segmentation
results because of the subjectivity of the user input. Therefore,
PCA is still a valuable tool for visualizing and exploring multi-
variate images because it requires no user input.
Linear discriminant analysis (LDA) is the best-known tech-
nique for supervised pattern recognition. LDA can use a sub-
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FIGURE 3. (a) Water-suppressed in vivo MR spectrum acquired from a voxel in the human brain. (inset) Water-unsuppressed spectrum from the
same voxel. Water suppression is accomplished by using additional rf pulses to saturate the water resonance. (b) After eddy current correc-
tion of (a), demonstrating that the metabolite peaks are phased with the phase of the water peak. (c) After filtering the residual water peak at
4.7 ppm of (b).
set of pixels of known tissue type, called a training set, to cal-
culate a classification model. It maximizes the ratio of the be-
tween-class and within-class variance of the tissue classes pres-
ent in the training set using linear combinations of the original
MR images. The calculated discriminant axes (lds), linear com-
binations of the MR images,
discriminate between the tissue
classes defined in the training
set. The first discriminant axis
(ld1) has the largest discrimina-
tive power, the next discrimi-
nant axes show less discrimina-
tive power with increasing ld
number. The use of LDA in
multivariate image segmenta-
tion is illustrated in Figure 2.
As in any segmentation tech-
nique requiring user input, the
training pixels need to be se-
lected by a human interpreter.
Different operators will select
different training sets (creating
inter-observer variations) at
different times (creating intra-
observer variations), resulting
in different segmented images
or tissue maps. A radiologist has
to assess the quality of these
calculated tissue maps because
there is no definitive method
that can verify the segmentation
results, which is a fundamental
problem in medical image pro-
cessing. Therefore, segmenta-
tion performance is usually de-
termined by the consistency or
sensitivity to operator input of
the applied method, not by the
accuracy of image segmenta-
tion. Several studies have shown
that the segmentation of brain
tumors strongly depends on
method and training data
(18–20). The major challenge
is to develop novel multivariate
segmentation techniques that
minimize operator input but are
robust enough to withstand
small variations in input.
Processing MR 
spectroscopic images
Eddy current correction.
Switching magnetic field gra-
dients induces small currents in
the magnet system called eddy
currents. These time-dependent currents disturb the field homo-
geneity and cause time-dependent frequency shifts of the reso-
nances in the selected voxel. This results in a distortion of the
spectrum after Fourier transformation of the time signal. Unlike
MRI, MRSI suffers from eddy currents because of the low sig-
nal intensity of the metabolite resonances. Therefore, to remove
eddy current distortions, both water-suppressed and water-un-
suppressed MRS images of a selected tissue slice are acquired in
a single MRSI examination, as shown in Figure 3a. 
For each voxel, eddy current distortions are corrected in the
time domain by dividing the water-suppressed signal by the
phase factor of the water signal for each data point. The influ-
ence of metabolite protons in the water-unsuppressed MRS
image is negligible (21). Figure 3b demonstrates a spectrum
corrected for eddy currents that is aligned in phase and in spec-
tral position to the water resonance peak within the voxel.
Residual water filtering. The MR spectrum corrected for
eddy currents in Figure 3b still contains a residual water peak.
This intense peak is usually filtered with a Hankel Lanczos sin-
gular value decomposition (22). The first few singular values
account for the intense water resonance and are subtracted from
the spectrum. The algorithm is applied in the time domain to
remove the long tails of the water peak that overlap some of the
metabolite peaks in the spectrum. The result of residual water
filtering of the MR spectrum in Figure 3b is shown in Figure 3c.
Phase and frequency shift correction. Small phase differences
between metabolite peaks in the MR spectrum remain after eddy
current correction. These remaining phase shifts are frequency-
dependent (first-order). Phase correction provides complete
absorption-mode spectra, which make interpretation and analy-
sis of the spectra easier. Interactive phase-correction facilities
are standard on MR instruments; however, fast and automatic
phasing is desirable for processing the large number of spectra
and obtaining unbiased results. 
Frequency shifts, or peak shifts between spectra of different
voxels, may also distort further spectra analysis. Although fre-
quency shifts induced by the spatial inhomogeneity of the rf
field are removed by eddy current correction, patient move-
ment between the acquisition of water-unsuppressed and
water-suppressed MRSI data may induce them. Patient move-
ment changes the coil loading, deteriorating the spatial homo-
geneity of the rf field inside the coil. A novel method has re-
cently been developed for quickly removing phase and frequency
shifts across a large series of single-resonance peaks (23). The
method works well on noisy and distorted MR spectra acquired
under in vivo conditions.
Pattern recognition. After preprocessing, MR spectra can
be classified according to their tissue identity. It is impossible to
categorize the processed MR spectra with respect to tissue
identity by visual inspection of the data, which makes pattern
recognition methods indispensable. These methods cluster the
spectra based on their mutual characteristics.
Selecting spectral features that provide the best discrimination
are important considerations when designing a pattern recogni-
tion model. For the pattern recognition of brain MR spectra, es-
timated levels of metabolites are used rather than the complete
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FIGURE 4. (a) (background)
Gadolinium-enhanced T1-
weighted MR image of a
brain tumor; (foreground)
grid of spectroscopic vox-
els. The symbols indicate
the group membership of
each spectrum, as deter-
mined with hierarchical
cluster analysis. (b) Two of
the MR spectra of the spec-
troscopic image: (i) Likely
originates from a healthy re-
gion; (ii) from a malignant
tumor region. The six quan-
tifiable resonances are indi-
cated: myo-inositol (mI) at
3.6 ppm, choline (Cho) at 3.2
ppm, creatine (Cr) at 3.0
ppm, N-acetyl aspartate
(NAA) at 2.6 and 2.0 ppm,
and lipids/lactate (Lip/Lac)
at 1.3 ppm.
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spectrum. The relative levels of NAA, Cho,
and Cr are derived from long echo-time spec-
tra by curve-fitting routines. Estimation con-
siderably reduces the dimension of the input
data, and spectral noise is omitted in the pat-
tern recognition. 
Metabolite levels from short echo-time spec-
tra are much harder to estimate. These spectra
are contaminated with broad peaks of nonrel-
evant macromolecules that distort the classifi-
cation performance. Short echo-time spectra
are usually fit in the time domain and are ad-
vantageous because complicated model func-
tions, similar to the measure peak shapes, can
be used. For example, the useful Voigt func-
tion can only be approximated in the frequen-
cy domain or must be calculated by numerical
integration (24). Nonlinear iterative optimiza-
tion methods such as the Levenberg–Marquardt
algorithm (25) are preferred in spectral fitting.
These methods allow any mathematical form
of the model function to be used for fitting the
spectra, including the Voigt function. 
Moreover, prior knowledge of, for exam-
ple, spectral position and relative amplitudes
can be incorporated into the model function
and improve the quantification of resonance
peaks (26). Recently, novel quantitation meth-
ods have been developed that operate on a
complete series of MR spectra instead of on
each separately (23, 27, 28). These have been
proposed for the fast and accurate quantita-
tion of resonances in series of relatively simple
in vivo MR spectra.
Figure 4a demonstrates the pattern recog-
nition of a spectroscopic image of a patient with
a brain tumor. Figure 4b gives two of the MR
spectra acquired from the patient’s brain. The
six resonance peaks labeled in the spectra were quantified and
subsequently normalized to the unsuppressed water signal
within the voxel. These normalized peaks define the input vec-
tor for the pattern recognizer for each spectrum.
The MR spectra, as represented by the aforementioned
input vectors, could roughly be divided into four different
groups with the use of hierarchical clustering. The result of hi-
erarchical clustering analysis is plotted as a dendrogram in Fig-
ure 5. Hierarchical clustering divides the data in large groups,
which are then subdivided into smaller groups until all the
“clusters” consist of only one sample. The division of the data
is based on the distances between the input vectors. The Eu-
clidean distance used in this particular patient study is a com-
mon distance measure.
PCA and LDA can also be used to cluster the MR spectra of
different patients with brain tumors. These methods also use
the six quantified resonances as input. With PCA, a set of lin-
ear combinations of the quantified peaks, called the principal
components (PCs), is constructed in such a way that as much
variation as possible is squeezed into the fewest possible new
variables. The PCA score plot defined by the first two PCs
yields a visualization of the spectra, which is based on the ma-
jority of the total information. With LDA, a set of linear com-
binations of the quantified peaks, called the discriminant func-
tions, is constructed, which maximally separates the different
groups of spectra labeled by the user. However, labeling of the
spectra is problematic because accurate histological characteri-
zation of all spectroscopic voxels is often impossible.
Thus, overall, a reliable discrimination among brain tumors
based on MRSI has yet to be accomplished, although progress
has been made (29). Some clinical trial studies involving multi-
ple sites have attempted to combine MRSI and MRI data to
improve tumor discrimination.
Prospects of combining MR images
On one hand, MRSI provides metabolic information at a low
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FIGURE 5. Hierarchical clustering of the MR data depicted in Figure 4.
The symbols on the left of the figure correspond with the symbols used in Figure 4. The horizon-
tal axis represents the Euclidean distance in arbitrary units.
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spatial resolution; on the other hand, MRI provides morpho-
logical information on a high spatial resolution. The levels of
metabolites differ in regions of the brain. For example, the
MR spectra of normal (i) and malignant tumor (ii) tissue in
Figure 4b clearly show differences. In addition, several studies
have demonstrated that levels of NAA, Cr, and Cho differ be-
tween white matter and gray matter and may be affected by
the contribution of cerebrospinal fluid (30–32). Therefore, to
classify the spectra accurately, the MR spectra must be nor-
malized to the tissue composition within the spectroscopic
voxel. 
Classifying the MR spectra on the basis of the estimated
metabolite levels and the fraction of white matter, gray matter,
cerebrospinal fluid, viable tumor, and necrosis within the spec-
troscopic voxel may be the best approach. Image and spectro-
scopic data are merged into one classifier or pattern recogniz-
er. Several groups are developing an overall classifier of MR
image and spectroscopic data (33). Such a classifier is also being
developed at the University Medical Center Nijmegen, The
Netherlands. 
The measurement protocol involves the acquisition of the
standard -, T1-, and T2-weighted spin-echo images—a T1-
weighted spin-echo image after administering the contrast
agent, a relative regional cerebral blood volume image, and a
short echo-time spectroscopic image. The five MR images de-
fine a multispectral or multivariate image in which each pixel
(image element) is characterized by its pixel intensities in the
five MR images. 
The multivariate image will be segmented into regions of
white matter, gray matter, cerebrospinal fluid, viable tumor,
and necrosis. Hopefully, patients will benefit from advanced
evaluation and treatment by combining the segmented image
with the spectroscopic image to improve the demarcation of
the brain tumors from healthy tissue and the delineation of tis-
sue heterogeneity within the tumor bed.
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